Skip to main content

tramentinib

Cancer Progression May Be Delayed With New Melanoma Treatment
By Sponsored Health Studies in the News

Cancer Progression May Be Delayed With New Melanoma Treatment

Researchers have discovered that a two-drug combination can delay treatment residence in patients with advanced melanoma. The kinase inhibitor drugs dabrafenib and tramentinib combined target different points in the same growth-factor pathway. This postponed the development of drug resistance in patients with BRAF-positive metastatic melanoma, the authors of the study claim. Melanoma is the most […]

Read More about Cancer Progression May Be Delayed With New Melanoma Treatment

min read